Evolution of the Antidepressant Prescribing in Alzheimer’s Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer’s Disease (BNA)

Treated Behavioral Symptoms and Mortality in Medicare Beneficiaries in Nursing Homes with Alzheimer's Disease and Related Dementias

(2015) Ting-Ying Huang et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis

(2015) Nicolas Cherbuin et al.   BMJ Open

Psychotropic and Cognitive-Enhancing Medication Use and Its Documentation in Contemporary Long-term Care Practice

(2014) Carlos Rojas-Fernandez et al.   ANNALS OF PHARMACOTHERAPY

Anti-Dementia Drugs and Co-Medication Among Patients with Alzheimer’s Disease

(2014) Seyed-Mohammad Fereshtehnejad et al.   DRUGS & AGING

High prevalence of psychotropic drug use among persons with and without Alzheimer׳s disease in Finnish nationwide cohort

(2014) Heidi Taipale et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine

(2014) S Banerjee et al.   HEALTH TECHNOLOGY ASSESSMENT

Neighborhood linking social capital as a predictor of psychiatric medication prescription in the elderly: A Swedish national cohort study

(2014) Jan Sundquist et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Consommation d’antipsychotiques chez les sujets atteints de maladie d’Alzheimer et maladies apparentées de la cohorte PACA-Alz 2010

(2014) Sylvie Bonin-Guillaume et al.   THERAPIE

Demographic and Neuropsychiatric Factors Associated With Off-label Medication Use in Frontotemporal Dementia and Alzheimer’s Disease

(2013) Maria Carmela Tartaglia et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Pharmacotherapeutic Management of Dementia Across Settings of Care

(2013) Gail B. Rattinger et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study

(2013) Carlos Martinez et al.   BMJ Open

Impact of the Food and Drug Administration’s antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatient and office-based settings

(2012) Vibha C.A. Desai et al.   Alzheimers & Dementia

History of depression prior to Alzheimer's disease and vascular dementia verified post-mortem

(2012) Hans Brunnström et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease

(2012) P. B. Rosenberg et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

The diagnosis of depression and use of antidepressants in nursing home residents with and without dementia

(2012) Iris F. M. van Asch et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients

(2011) A. Marengoni et al.   INTERNATIONAL PSYCHOGERIATRICS

Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort

(2011) S. Gonfrier et al.   Journal of Nutrition Health & Aging

Psychotropic Medication Burden and Factors Associated with Antipsychotic Use: An Analysis of a Population-Based Sample of Community-Dwelling Older Persons with Dementia

(2011) YongJoo Rhee et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Antidepressant use in Alzheimer's disease patients: results of the REAL.FR cohort

(2009) Christophe Arbus et al.   INTERNATIONAL PSYCHOGERIATRICS